Literature DB >> 26594334

An unexpected effect of TNF-α on F508del-CFTR maturation and function.

Iwona Pranke1, Monika Hollenhorst1, Nathalie Servel1, Christelle Moquereau1, Danielle Tondelier1, Aurélie Hatton1, Sara Bitam1, Valérie Urbach1, Isabelle Sermet-Gaudelus1, Alexandre Hinzpeter2, Aleksander Edelman1.   

Abstract

Cystic fibrosis (CF) is a multifactorial disease caused by mutations in the cystic fibrosis transmembrane conductance regulator gene ( CFTR), which encodes a cAMP-dependent Cl (-) channel. The most frequent mutation, F508del, leads to the synthesis of a prematurely degraded, otherwise partially functional protein. CFTR is expressed in many epithelia, with major consequences in the airways of patients with CF, characterized by both fluid transport abnormalities and persistent inflammatory responses. The relationship between the acute phase of inflammation and the expression of wild type (WT) CFTR or F508del-CFTR is poorly understood. The aim of the present study was to investigate this effect. The results show that 10 min exposure to TNF-alpha (0.5-50ng/ml) of F508del-CFTR-transfected HeLa cells and human bronchial cells expressing F508del-CFTR in primary culture (HBE) leads to the maturation of F508del-CFTR and induces CFTR chloride currents. The enhanced CFTR expression and function upon TNFα is sustained, in HBE cells, for at least 24 h. The underlying mechanism of action involves a protein kinase C (PKC) signaling pathway, and occurs through insertion of vesicles containing F508del-CFTR to the plasma membrane, with TNFα behaving as a corrector molecule. In conclusion, a novel and unexpected action of TNFα has been discovered and points to the importance of systematic studies on the roles of inflammatory mediators in the maturation of abnormally folded proteins in general and in the context of CF in particular.

Entities:  

Keywords:  CFTR; Cystic fibrosis; F508del-CFTR; chloride channel; correctors; epithelium; inflammation; tumor necrosis factor-alpha

Year:  2015        PMID: 26594334     DOI: 10.12688/f1000research.6683.2

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  10 in total

1.  SFPQ rescues F508del-CFTR expression and function in cystic fibrosis bronchial epithelial cells.

Authors:  Parameet Kumar; Dharmendra Kumar Soni; Chaitali Sen; Mads B Larsen; Krystyna Mazan-Mamczarz; Yulan Piao; Supriyo De; Myriam Gorospe; Raymond A Frizzell; Roopa Biswas
Journal:  Sci Rep       Date:  2021-08-17       Impact factor: 4.996

2.  Enhanced Expression of Human Epididymis Protein 4 (HE4) Reflecting Pro-Inflammatory Status Is Regulated by CFTR in Cystic Fibrosis Bronchial Epithelial Cells.

Authors:  Zsolt Bene; Zsolt Fejes; Tibor Gabor Szanto; Ferenc Fenyvesi; Judit Váradi; Luka A Clarke; Gyorgy Panyi; Milan Macek; Margarida D Amaral; István Balogh; Béla Nagy
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

Review 3.  Epithelial Anion Transport as Modulator of Chemokine Signaling.

Authors:  Andrea Schnúr; Péter Hegyi; Simon Rousseau; Gergely L Lukacs; Guido Veit
Journal:  Mediators Inflamm       Date:  2016-06-12       Impact factor: 4.711

4.  Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators.

Authors:  Iwona M Pranke; Aurélie Hatton; Juliette Simonin; Jean Philippe Jais; Françoise Le Pimpec-Barthes; Ania Carsin; Pierre Bonnette; Michael Fayon; Nathalie Stremler-Le Bel; Dominique Grenet; Matthieu Thumerel; Julie Mazenq; Valerie Urbach; Myriam Mesbahi; Emanuelle Girodon-Boulandet; Alexandre Hinzpeter; Aleksander Edelman; Isabelle Sermet-Gaudelus
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

5.  New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation.

Authors:  Sara Bitam; Ahmad Elbahnsi; Geordie Creste; Iwona Pranke; Benoit Chevalier; Farouk Berhal; Isabelle Callebaut; Christine Gravier-Pelletier; Isabelle Sermet-Gaudelus; Brice Hoffmann; Nathalie Servel; Danielle Tondelier; Aurelie Hatton; Christelle Moquereau; Mélanie Faria Da Cunha; Alexandra Pastor; Agathe Lepissier; Alexandre Hinzpeter; Jean-Paul Mornon; Guillaume Prestat; Aleksander Edelman
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

Review 6.  Impact of Airway Inflammation on the Efficacy of CFTR Modulators.

Authors:  Carla M P Ribeiro; Martina Gentzsch
Journal:  Cells       Date:  2021-11-22       Impact factor: 6.600

7.  Cystic Fibrosis: Systems Biology Analysis from Homozygous p.Phe508del Variant Patients' Samples Reveals Perturbations in Tissue-Specific Pathways.

Authors:  Joice de Faria Poloni; Thaiane Rispoli; Maria Lucia Rossetti; Cristiano Trindade; José Eduardo Vargas
Journal:  Biomed Res Int       Date:  2021-12-02       Impact factor: 3.411

8.  Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators.

Authors:  Tayyab Rehman; Philip H Karp; Ping Tan; Brian J Goodell; Alejandro A Pezzulo; Andrew L Thurman; Ian M Thornell; Samantha L Durfey; Michael E Duffey; David A Stoltz; Edward F McKone; Pradeep K Singh; Michael J Welsh
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 19.456

9.  Dataset of differential lipid raft and global proteomes of SILAC-labeled cystic fibrosis cells upon TNF -α stimulation.

Authors:  C Chhuon; I Pranke; F Borot; D Tondelier; J Lipecka; J Fritsch; M Chanson; A Edelman; M Ollero; I C Guerrera
Journal:  Data Brief       Date:  2016-08-20

10.  Integrative chemogenomic analysis identifies small molecules that partially rescue ΔF508-CFTR for cystic fibrosis.

Authors:  Rachel A Hodos; Matthew D Strub; Shyam Ramachandran; Ella A Meleshkevitch; Dmitri Y Boudko; Robert J Bridges; Joel T Dudley; Paul B McCray
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.